SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-00-000468
Filing Date
2000-03-28
Accepted
2000-03-28 00:00:00
Documents
1
Period of Report
1997-03-28

Document Format Files

Seq Description Document Type Size
1 3 2755
  Complete submission text file 0000919574-00-000468.txt   4717
Mailing Address 8320 GUILFORD ROAD SUITE C COLUMBIA MD 21046
Business Address 8320 GUILFORD RD SUITE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-26770 | Film No.: 581577
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 730 FIFTH AVENUE 15TH FL NEW YORK NY 10019
Business Address 730 FIFTH AVENUE 15TH FLOOR NEW YORK NY 10019 2125741286
ANACONDA OPPORTUNITY FUND L P (Reporting) CIK: 0001021863 (see all company filings)

IRS No.: 521945748 | State of Incorp.: DE | Fiscal Year End: 0630